Cargando…

Efficacy and Safety of Mizoribine for the Treatment of Refractory Nephrotic Syndrome: Protocol for a Multicenter, Controlled, Open-label, Randomized Controlled Trial

BACKGROUND: Nephrotic syndrome that is resistant to steroid therapy is termed refractory nephrotic syndrome (RNS), a condition that is associated with an increased risk of end-stage renal disease. Immunosuppressants are used to treat RNS; however, prolonged use may lead to significant adverse effect...

Descripción completa

Detalles Bibliográficos
Autores principales:	Dong, Zheyi, Zhou, Jianhui, Xu, Zhonggao, Ni, Zhaohui, He, Yani, Lin, Hongli, Jiang, Gengru, Sun, Xuefeng, Zhang, Li, Chen, Xiangmei
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	JMIR Publications 2023
Materias:	Protocol
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10337463/ https://www.ncbi.nlm.nih.gov/pubmed/36990111 http://dx.doi.org/10.2196/46101

Ejemplares similares

Safety and effectiveness evaluation of a domestic peritoneal dialysis fluid packed in non-PVC bags: study protocol for a randomized controlled trial
por: Zhou, Jianhui, et al.
Publicado: (2015)

Mizoribine therapy combined with steroids and mizoribine blood concentration monitoring for idiopathic membranous nephropathy with steroid-resistant nephrotic syndrome
por: Saito, Takao, et al.
Publicado: (2016)

Study protocol: high-dose mizoribine with prednisolone therapy in short-term relapsing steroid-sensitive nephrotic syndrome to prevent frequent relapse (JSKDC05 trial)
por: Hama, Taketsugu, et al.
Publicado: (2018)

Leflunomide plus low-dose prednisone in patients with progressive IgA nephropathy: a multicenter, prospective, randomized, open-labeled, and controlled trial
por: Ni, Zhaohui, et al.
Publicado: (2021)

Efficacy and safety of polysaccharide iron complex capsules compared with iron sucrose in hemodialysis patients: study protocol for a randomized, open-label, positive control, multicenter trial (IHOPE)
por: Lu, Renhua, et al.
Publicado: (2021)

Acupuncture for patients with mild hypertension: study protocol of an open-label multicenter randomized controlled trial
por: Li, Juan, et al.
Publicado: (2013)

Successful Treatment of Adult IgA Nephropathy with Nephrotic-Level Proteinuria by Combination Therapy Including Long-Term Coadministration of Mizoribine
por: Okonogi, Hideo, et al.
Publicado: (2012)

Sitafloxacin- Versus Moxifloxacin-Based Sequential Treatment for Mycoplasma Genitalium Infections: Protocol for a Multicenter, Open-Label Randomized Controlled Trial
por: Ando, Naokatsu, et al.
Publicado: (2023)

Mizoribine: A New Approach in the Treatment of Renal Disease
por: Kawasaki, Yukihiko
Publicado: (2009)

Efficacy and Safety of Inhaled Ciclesonide in Treating Patients With Asymptomatic or Mild COVID-19 in the RACCO Trial: Protocol for a Multicenter, Open-label, Randomized Controlled Trial
por: Terada-Hirashima, Junko, et al.
Publicado: (2020)

Guided meditation for vision acuity training on adolescent myopia: study protocol for an open-label, prospective, multicenter, randomized controlled trial
por: Li, Yibo, et al.
Publicado: (2022)

Methadone rotation versus other opioid rotation for refractory cancer induced bone pain: protocol of an exploratory randomised controlled open-label study
por: Michael, Natasha, et al.
Publicado: (2023)

Involvement of Multiple Transporters-mediated Transports in Mizoribine and Methotrexate Pharmacokinetics
por: Murakami, Teruo, et al.
Publicado: (2012)

Safety and Efficacy of Ranibizumab and Luseogliflozin Combination Therapy in Patients with Diabetic Macular Edema: Protocol for a Multicenter, Open-Label Randomized Controlled Trial
por: Ishibashi, Ryoichi, et al.
Publicado: (2020)

Rituximab treatment for refractory nephrotic syndrome in adults: a multicenter retrospective study
por: Ma, Xiaoyan, et al.
Publicado: (2023)

Efficacy and safety of adding mizoribine to standard treatment in patients with immunoglobulin A nephropathy: A randomized controlled trial
por: Hirai, Keiji, et al.
Publicado: (2017)

Efficacy of chloroquine versus lopinavir/ritonavir in mild/general COVID-19 infection: a prospective, open-label, multicenter, randomized controlled clinical study
por: Liu, Xi, et al.
Publicado: (2020)

Study protocol: mycophenolate mofetil as maintenance therapy after rituximab treatment for childhood-onset, complicated, frequently-relapsing nephrotic syndrome or steroid-dependent nephrotic syndrome: a multicenter double-blind, randomized, placebo-controlled trial (JSKDC07)
por: Horinouchi, Tomoko, et al.
Publicado: (2018)

The Immunosuppressive Agent Mizoribine Monophosphate Is an Inhibitor of the Human RNA Capping Enzyme
por: Picard-Jean, Frédéric, et al.
Publicado: (2013)

Evaluation of Mizoribine as an Immunosuppressant in Subrenal Capsule Assay Using Immunocompetent Mice
por: Chen, Dong‐Yi, et al.
Publicado: (1990)

Efficacy and safety of rituximab in childhood-onset, difficult-to-treat nephrotic syndrome: A multicenter open-label trial in Korea
por: Ahn, Yo Han, et al.
Publicado: (2018)

The Fetal Growth Restriction at Term Managed by Angiogenic Factors Versus Feto-Maternal Doppler (GRAFD) Trial to Avoid Adverse Perinatal Outcomes: Protocol for a Multicenter, Open-Label, Randomized Controlled Trial
por: Garcia-Manau, Pablo, et al.
Publicado: (2022)

Empirical treatment against cytomegalovirus and tuberculosis in HIV-infected infants with severe pneumonia: study protocol for a multicenter, open-label randomized controlled clinical trial
por: Rojo, Pablo, et al.
Publicado: (2022)

Spray on skin for diabetic foot ulcers: an open label randomised controlled trial
por: Manning, Laurens, et al.
Publicado: (2019)

Diagnostic Ability of a Smartphone App for Dry Eye Disease: Protocol for a Multicenter, Open-Label, Prospective, and Cross-sectional Study
por: Nagino, Ken, et al.
Publicado: (2023)

Angiotensin-converting enzyme inhibitor for post-transcatheter aortic valve implantation patients: study protocol for a multicenter randomized, open-label blinded endpoint control trial
por: Liao, Yan Biao, et al.
Publicado: (2021)

Remission effect of Canagliflozin in patients with newly diagnosed type 2 diabetes mellitus: a protocol for a multicenter, parallel-group, randomized, controlled, open-label trial
por: Yang, Xue, et al.
Publicado: (2023)

Efficacy of a Green Banana–Mixed Diet in the Management of Persistent Diarrhea: Protocol for an Open-Labeled, Randomized Controlled Trial
por: Sarmin, Monira, et al.
Publicado: (2020)

A three-arm, multicenter, open-label randomized controlled trial of hydroxychloroquine and low-dose prednisone to treat recurrent pregnancy loss in women with undifferentiated connective tissue diseases: protocol for the Immunosuppressant regimens for LIving FEtuses (ILIFE) trial
por: Yang, Shaoying, et al.
Publicado: (2020)

In Vitro and in Vivo Antiviral Activity of Mizoribine Against Foot-And-Mouth Disease Virus
por: Li, Shi-Fang, et al.
Publicado: (2019)

Mizoribine treatment in an elderly diabetic patient with antisynthetase-associated interstitial lung disease
por: Nagai, Kei, et al.
Publicado: (2020)

Fanconi syndrome in an elderly patient with membranous nephropathy during treatment with the immunosuppressant mizoribine
por: Nishikawa, Sho, et al.
Publicado: (2022)

Gallium-68-labeled fibroblast activation protein inhibitor-46 PET in patients with resectable or borderline resectable pancreatic ductal adenocarcinoma: A phase 2, multicenter, single arm, open label non-randomized study protocol
por: Karbhari, Aashna, et al.
Publicado: (2023)

Conversion from mycophenolate mofetil to mizoribine in the early stages of BK polyomavirus infection could improve kidney allograft prognosis: a single-center study from China
por: Li, Ping, et al.
Publicado: (2021)

Reinducing Radioiodine-Sensitivity in Radioiodine-Refractory Thyroid Cancer Using Lenvatinib (RESET): Study Protocol for a Single-Center, Open Label Phase II Trial
por: Dotinga, Maaike, et al.
Publicado: (2022)

Evaluation of convalescent plasma versus standard of care for the treatment of COVID-19 in hospitalized patients: study protocol for a phase 2 randomized, open-label, controlled, multicenter trial
por: Diago-Sempere, Elena, et al.
Publicado: (2021)

An Exploratory Trial of EPI-589 in Amyotrophic Lateral Sclerosis (EPIC-ALS): Protocol for a Multicenter, Open-Labeled, 24-Week, Single-Group Study
por: Haji, Shotaro, et al.
Publicado: (2023)

Multicenter study of lumen-apposing metal stents with or without pigtail in endoscopic ultrasound-guided biliary drainage for malignant obstruction—BAMPI TRIAL: an open-label, randomized controlled trial protocol
por: Garcia-Sumalla, Albert, et al.
Publicado: (2022)

Advanced practice nurse intervention versus usual care for hypertension control: study protocol for an open-label randomized controlled trial
por: Vay-Demouy, Juliette, et al.
Publicado: (2023)

Nitazoxanide protects cats from feline calicivirus infection and acts synergistically with mizoribine in vitro
por: Cui, Zhanding, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_4fe8f0u3ce7asrl5anbec7inqi